“Our results suggest that oscillometry . . . may serve as valuable, noninvasive biomarkers for early detection, risk stratification, and longitudinal monitoring of IPF,” the authors concluded.

Johnson & Johnson today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in combination ...

Ten percent complete response and rapid, durable antitumor activity reported with RYBREVANT FASPRO; results surpass current standards of care RARITAN, N.J., Feb. 19 ...

New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT ...

Pfizer Inc. and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive results from the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for ...

New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...

Fox is making another appointment with Best Medicine. The network has renewed the dramedy starring Josh Charles for a second ...

The adaptation of the British staple Doc Martin currently stands as Fox’s second-largest 7-day total multi-platform audience ...

The original Medical Research Council (MRC) dyspnoea scale was developed by the British MRC in the 1950s, and it was first formally published in 1961 in a study on chronic bronchitis.1 It was designed ...

London, United Kingdom: British pharmaceutical group GSK reported Wednesday a sharp rise in net profit last year, boosted by strong HIV, respiratory and cancer drug sales as it recovered from costly ...

A 91-year-old man was admitted to the hospital with weight loss, dyspnea, and eosinophilia. An anteroposterior chest radiograph obtained 2 months earlier showed bibasilar patchy opacities. A ...